Lipid metabolism of Acetobacter pasteurianus and its main components with hypoglycemic effects

doi:10.4239/wjd.v16.i6.103370

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (225)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

HTML

129

Figures (1-9)

Sum=181

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=36

Jun 15, 2025 (publication date) through Jun 16, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Jun 15, 2025; 16(6): 103370
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.103370

Lipid metabolism of Acetobacter pasteurianus and its main components with hypoglycemic effects

Wen-Yan Xu, Wen-Ting Zhou, Jia-Zi Luo, Yu-Ying Jiang, Kai Zhang, Shu-Yan Zhang, Ping-Sheng Liu, Hong-Yu Wei, Yan-Qiang Huang

Wen-Yan Xu, Wen-Ting Zhou, Jia-Zi Luo, Yu-Ying Jiang, Hong-Yu Wei, Yan-Qiang Huang, Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China

Wen-Yan Xu, Wen-Ting Zhou, Jia-Zi Luo, Yu-Ying Jiang, Hong-Yu Wei, Guangxi Zhuang Autonomous Region Engineering Research Center of Clinical Prevention and Control Technology and Leading Drug for Microorganisms with Drug Resistance in Border Ethnic Areas, Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China

Wen-Yan Xu, Wen-Ting Zhou, Jia-Zi Luo, Yu-Ying Jiang, Hong-Yu Wei, The University Key Laboratory of prevention and Control to Drug-resistant Microbial Infection in Guangxi, Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China

Kai Zhang, School of Food Science and Engineering, Key Laboratory of Food Nutrition and Functional Food of Hainan Province, Hainan University, Haikou 570228, Hainan Province, China

Shu-Yan Zhang, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing Institute of Infectious Diseases, Beijing 100015, China

Ping-Sheng Liu, National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

Ping-Sheng Liu, University of Chinese Academy of Sciences, Beijing 100049, China

Co-corresponding authors: Hong-Yu Wei and Yan-Qiang Huang.

Author contributions: Xu WY performed the experiments and acquired the data; Zhou WT and Luo JZ modified and enhanced the experimental images; Jiang YY interpreted and analyzed the data; Zhang K, Zhang SY, and Liu PS wrote or guided the writing of the manuscript; Wei HY and Huang YQ designed, checked, and finalized the manuscript, and contributed equally to this work; All authors approved the final version of the article.

Supported by the Guangxi Science and Technology Major Projects, No. AA23073012; and the National Natural Science Foundation of China, No. 32360035 and No. 32060018.

Institutional review board statement: This study did not involve human experimentation.

Institutional animal care and use committee statement: All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of the Youjiang Medical University for Nationalities (No. 2023071101).

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

ARRIVE guidelines statement: The authors have read the ARRIVE Guidelines, and the manuscript was prepared and revised according to the ARRIVE Guidelines.

Data sharing statement: All data included in this study are available upon request by contact with the corresponding author at why-825@163.com.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Hong-Yu Wei, MD, Assistant Professor, Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, No. 98 Countryside Road, Baise 533000, Guangxi Zhuang Autonomous Region, China. why-825@163.com

Received: December 20, 2024
Revised: March 14, 2025
Accepted: April 25, 2025
Published online: June 15, 2025
Processing time: 176 Days and 10.1 Hours

Core Tip

Core Tip: Research has shown that Acetobacter pasteurianus plays an effective role in alleviating diabetes. Therefore, we investigated its lipid metabolism, main lipid components, and hypoglycemic effects. We found that A. pasteurianus produces various lipids, with coenzyme Q9 and oleic acid being the most abundant components that have hypoglycemic effects, and can repair damaged pancreatic tissues. This provides a theoretical basis for promoting A. pasteurianus for its antidiabetic properties.